Advertisement
Canada markets close in 4 hours 46 minutes
  • S&P/TSX

    22,417.75
    +158.59 (+0.71%)
     
  • S&P 500

    5,205.63
    +17.96 (+0.35%)
     
  • DOW

    39,235.40
    +179.01 (+0.46%)
     
  • CAD/USD

    0.7309
    +0.0021 (+0.28%)
     
  • CRUDE OIL

    79.44
    +0.45 (+0.57%)
     
  • Bitcoin CAD

    84,728.09
    -539.09 (-0.63%)
     
  • CMC Crypto 200

    1,324.71
    +24.61 (+1.89%)
     
  • GOLD FUTURES

    2,340.30
    +18.00 (+0.78%)
     
  • RUSSELL 2000

    2,066.02
    +10.88 (+0.53%)
     
  • 10-Yr Bond

    4.4890
    -0.0030 (-0.07%)
     
  • NASDAQ

    16,338.84
    +36.08 (+0.22%)
     
  • VOLATILITY

    13.09
    +0.09 (+0.69%)
     
  • FTSE

    8,393.87
    +39.82 (+0.48%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • CAD/EUR

    0.6776
    0.0000 (0.00%)
     

Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares This Year?

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Insmed Incorporated (NASDAQ:INSM), you may well want to know whether insiders have been buying or selling.

What Is Insider Buying?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.

Insider transactions are not the most important thing when it comes to long-term investing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

ADVERTISEMENT

Check out our latest analysis for Insmed

The Last 12 Months Of Insider Transactions At Insmed

The President, William Lewis, made the biggest insider sale in the last 12 months. That single transaction was for US$416k worth of shares at a price of US$3.40 each. So it's clear an insider wanted to take some cash off the table, even below the current price of US$19.65. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was 100% of William Lewis's holding. William Lewis was the only individual insider to sell over the last year.

You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

NasdaqGS:INSM Recent Insider Trading, November 2nd 2019
NasdaqGS:INSM Recent Insider Trading, November 2nd 2019

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 0.8% of Insmed shares, worth about US$15m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Insmed Tell Us?

The fact that there have been no Insmed insider transactions recently certainly doesn't bother us. Still, the insider transactions at Insmed in the last 12 months are not very heartening. The modest level of insider ownership is, at least, some comfort. Of course, the future is what matters most. So if you are interested in Insmed, you should check out this free report on analyst forecasts for the company.

Of course Insmed may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.